BC
BDSI

Broadfin Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Broadfin Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-500,000
Closed -$2.4M – 94
2015
Q4 		$2.4M Buy
500,000
+250,000
+100% +$1.42M 0.15% 79
2015
Q3 		$1.39M Sell
250,000
-500,000
-67% -$3.69M 0.08% 88
2015
Q2 		$5.97M Buy
+750,000
New +$6.44M 0.32% 68

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital's BDSI Position: Q4 2019 in Review

Broadfin Capital held its BioDelivery Sciences International, Inc. (BDSI) position steady in Q4 2019 at 4,300,066 shares worth $27.2M. The position accounts for 3.64% of the portfolio, ranked #5.

Broadfin Capital first reported a position in BDSI in Q2 2013 and has held it in 27 quarters since. The position peaked at $40.7M in Q2 2014. 157 funds tracked by Wall St. Rank hold BDSI as of Q4 2019.

  • Broadfin Capital held 4,300,066 shares of BioDelivery Sciences International, Inc. worth $27.2M as of Q4 2019.
  • Broadfin Capital left its BioDelivery Sciences International, Inc. share count unchanged in Q4 2019.
  • BioDelivery Sciences International, Inc. made up 3.64% of Broadfin Capital's portfolio in Q4 2019, its #5 holding.
  • Broadfin Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and has held it in 27 quarters since.
  • Broadfin Capital's BioDelivery Sciences International, Inc. position peaked at $40.7M in Q2 2014.
  • 157 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.